Cargando…

Dysregulations in the PI3K pathway and targeted therapies for head and neck squamous cell carcinoma

The phosphoinositide 3-kinase (PI3K) signaling pathway is the most commonly mutated pathway in head and neck squamous cell carcinoma (HNSCC). There are several drugs targeting members of the PI3K signaling pathway in development for HNSCC. In this article, we review the genetic alterations reported...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Yi, Dodhia, Sonam, Su, Gloria H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400658/ https://www.ncbi.nlm.nih.gov/pubmed/28108737 http://dx.doi.org/10.18632/oncotarget.14729

Ejemplares similares

Targeting PI3K/AKT/mTOR Signaling Pathway as a Radiosensitization in Head and Neck Squamous Cell Carcinomas
por: Su, Yu-Chieh, et al.
Publicado: (2022)

Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas
por: García-Carracedo, Darío, et al.
Publicado: (2016)

Targeting phosphoinositide 3-kinase (PI3K) in head and neck squamous cell carcinoma (HNSCC)
por: Jung, Kyungsuk, et al.
Publicado: (2018)

Role of PI3K/AKT pathway in squamous cell carcinoma with an especial focus on head and neck cancers
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2022)

TAB2 Promotes the Biological Functions of Head and Neck Squamous Cell Carcinoma Cells via EMT and PI3K Pathway
por: Liu, Huijuan, et al.
Publicado: (2022)

Metadherin Regulation of Vascular Endothelial Growth Factor Expression Is Dependent Upon the PI3K/Akt Pathway in Squamous Cell Carcinoma of the Head and Neck
por: Zhu, Gang-cai, et al.
Publicado: (2015)

Tumour-specific PI3K inhibition via nanoparticle-targeted delivery in head and neck squamous cell carcinoma
por: Mizrachi, Aviram, et al.
Publicado: (2017)

The Significance of the Dysregulation of Canonical Wnt Signaling in Head and Neck Squamous Cell Carcinomas
por: Paluszczak, Jarosław
Publicado: (2020)

Co-Targeting the EGFR and PI3K/Akt Pathway to Overcome Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma: What about Autophagy?
por: Zaryouh, Hannah, et al.
Publicado: (2022)

Molecular Pathways and Druggable Targets in Head and Neck Squamous Cell Carcinoma
por: Kordbacheh, Farzaneh, et al.
Publicado: (2021)

Chromatin dysregulation associated with NSD1 mutation in head and neck squamous cell carcinoma
por: Farhangdoost, Nargess, et al.
Publicado: (2021)

Dual Inhibition of Autophagy and PI3K/AKT/MTOR Pathway as a Therapeutic Strategy in Head and Neck Squamous Cell Carcinoma
por: Bernard, Monique, et al.
Publicado: (2020)

PI3K pathway mutation predicts an activated immune microenvironment and better immunotherapeutic efficacy in head and neck squamous cell carcinoma
por: Wang, Libo, et al.
Publicado: (2023)

Targeted therapy for head and neck squamous cell carcinoma microenvironment
por: Guo, Zhaomeng, et al.
Publicado: (2023)

PI3k inhibitors (BKM120 and BYL719) as radiosensitizers for head and neck squamous cell carcinoma during radiotherapy
por: Chuang, Fu-Cheng, et al.
Publicado: (2021)

Illuminating biological pathways for drug targeting in head and neck squamous cell carcinoma
por: Choonoo, Gabrielle, et al.
Publicado: (2019)

Knockdown of HPIP Inhibits the Proliferation and Invasion of Head-and-Neck Squamous Cell Carcinoma Cells by Regulating PI3K/Akt Signaling Pathway
por: Chen, Yangjing, et al.
Publicado: (2016)

Immune Checkpoints Pathways in Head and Neck Squamous Cell Carcinoma
por: Veigas, Florencia, et al.
Publicado: (2021)

Plasma Vascular Endothelial Growth Factor Dysregulation in Defining Aggressiveness of Head and Neck Squamous Cell Carcinoma
por: Kulapaditharom, Boonchu, et al.
Publicado: (2012)

Identification of Molecular Subtypes in Head and Neck Squamous Cell Carcinoma Based on Dysregulated Immune LncRNAs
por: Du, Yucong, et al.
Publicado: (2022)

Mammalian target of rapamycin and head and neck squamous cell carcinoma
por: Liao, Yu-Min, et al.
Publicado: (2011)

An update on angiogenesis targeting in head and neck squamous cell carcinoma
por: Micaily, Ida, et al.
Publicado: (2020)

Therapeutic Targeting of MYC in Head and Neck Squamous Cell Carcinoma
por: Liu, Shuo, et al.
Publicado: (2022)

Predictive Value of EGFR-PI3K-AKT-mTOR-Pathway Inhibitor Biomarkers for Head and Neck Squamous Cell Carcinoma: A Systematic Review
por: de Kort, W. W. B., et al.
Publicado: (2021)

Clinical Development of Molecular Targeted Therapy in Head and Neck Squamous Cell Carcinoma
por: Gougis, Paul, et al.
Publicado: (2019)

Guggulsterone Targets Smokeless Tobacco Induced PI3K/Akt Pathway in Head and Neck Cancer Cells
por: Macha, Muzafar A., et al.
Publicado: (2011)

PI3K/AKT/mTOR Signaling Pathway in HPV-Driven Head and Neck Carcinogenesis: Therapeutic Implications
por: Aguayo, Francisco, et al.
Publicado: (2023)

Dysregulated cholinergic network as a novel biomarker of poor prognostic in patients with head and neck squamous cell carcinoma
por: Castillo-González, Ana Cristina, et al.
Publicado: (2015)

Alcohol-dysregulated miR-30a and miR-934 in head and neck squamous cell carcinoma
por: Saad, Maarouf A., et al.
Publicado: (2015)

Preclinical evaluation of dual PI3K-mTOR inhibitors and histone deacetylase inhibitors in head and neck squamous cell carcinoma
por: Erlich, R B, et al.
Publicado: (2012)

STC2 promotes head and neck squamous cell carcinoma metastasis through modulating the PI3K/AKT/Snail signaling
por: Yang, Shuwen, et al.
Publicado: (2016)

Immune checkpoint pathways in immunotherapy for head and neck squamous cell carcinoma
por: Mei, Zi, et al.
Publicado: (2020)

Roles of the Wnt Signaling Pathway in Head and Neck Squamous Cell Carcinoma
por: Xie, Jing, et al.
Publicado: (2021)

The Role of Hedgehog Signaling Pathway in Head and Neck Squamous Cell Carcinoma
por: Cierpikowski, Piotr, et al.
Publicado: (2023)

Co-targeting EGFR and IKKβ/NF-κB signalling pathways in head and neck squamous cell carcinoma: a potential novel therapy for head and neck squamous cell cancer
por: Li, Zhipeng, et al.
Publicado: (2018)

Targeting EGF-receptor-signalling in squamous cell carcinomas of the head and neck
por: Reuter, C W M, et al.
Publicado: (2007)

Enhanced Chemosensitivity by Targeting Nanog in Head and Neck Squamous Cell Carcinomas
por: Huang, Chuan-En, et al.
Publicado: (2014)

Targeted treatment of head and neck squamous-cell carcinoma: potential of lapatinib
por: Gandhi, Mitul D, et al.
Publicado: (2014)

Therapeutic Targeting of BRD4 in Head Neck Squamous Cell Carcinoma
por: Wu, Yaping, et al.
Publicado: (2019)

Targeting the Immune Microenvironment in the Treatment of Head and Neck Squamous Cell Carcinoma
por: Wang, Hui-Ching, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_q2uj1vdksi8s0fipavhs3e7a97